Investigators used the Automated Student Health Record (ASHR) maintained by the NYC Department of Health and Mental Hygiene to estimate childhood diabetes prevalence across school years 2010-11 to 2021-22. The cohort included non-homeschooled New York City Public Schools students aged 5–17, enrolled in pre-K through grade 12. The study team reported an analytic dataset of 2,167,033 unique students drawn from ASHR records.
The primary outcome was annual prevalence of type 1 diabetes and type 2 diabetes expressed per 1,000 students each school year. The authors analyzed year-to-year trends with particular attention to changes beginning in 2016-17 and carrying through the post-COVID-19 school year 2021-22. The published abstract lists the sample size and outcome metric; it does not report additional methodological details such as case definition algorithms, coding rules, or missing-data procedures in the abstract text.
In 2021-22, the highest measured prevalence of type 1 diabetes appeared among White students, at 2.73 per 1,000 (95% CI: 2.44, 2.97). Prevalence was also highest in the 15–17 age group, measured at 2.24 per 1,000 (95% CI: 2.03, 2.45). The investigators reported no statistically significant increase in type 1 diabetes prevalence since 2016-17 (p > 0.050). The abstract does not provide subgroup time-series data beyond those summary estimates, nor does it present effect sizes for every demographic stratum in the abstract itself.
The study team observed a near 40% increase in type 2 diabetes prevalence between 2016-17 and 2021-22 (p < 0.050). That rise occurred across most demographic groups in the dataset. The authors noted that increases were largest among older students, students of color, those with obesity, and students living in high-poverty areas, though they reported that most of those increases were not statistically different from increases observed in other groups. The abstract provides the significant overall change for type 2 diabetes but does not detail year-by-year rates for every subgroup in the summary text.
Among measured subgroups in 2021-22, students with obesity had the highest reported type 2 diabetes prevalence at 2.35 per 1,000 (95% CI: 1.96, 2.74). The investigators reported the largest relative increases in type 2 diabetes prevalence for older adolescents and for students from racial and socioeconomic groups experiencing higher baseline risk, but they qualified that most subgroup increases did not significantly differ from one another. The abstract does not specify the obesity classification method or the poverty thresholds used; those methodological details were not included in the abstract text.
Authors argued that systems modeled on ASHR can be a valuable resource for tracking chronic conditions among youth at scale. They demonstrated feasibility by producing citywide prevalence estimates across more than two million unique student records spanning multiple academic years. The abstract characterizes ASHR as a potential tool for broader public health monitoring, but it does not describe implementation steps, validation studies, or external generalizability testing within the abstract itself.
The manuscript discloses that all authors were employees of the NYC Department of Health and Mental Hygiene at the time of the study. That competing interest is reported in the conflict-of-interest statement. The abstract does not provide granular methodological details—such as the specific ASHR data elements used to classify diabetes type, sensitivity analyses, or handling of incomplete records—so readers seeking those particulars must consult the full text. The final documented constraint in the public abstract is the authors' institutional employment; the abstract does not enumerate additional limitations, regulatory milestones, or unanswered clinical questions beyond what is reported here.